Phantom Neuro, a startup based in Austin, has raised US$19 million in funding to advance its implantable technology for controlling prosthetic limbs.

The round was led by German prosthetics giant Ottobock, with participation from Breakout Ventures, Draper Associates, Actual VC, and Brown Advisory.

This brings Phantom Neuro’s total funding to US$28 million, though its valuation remains undisclosed.

The company’s device, implanted under the skin, translates nerve signals from amputees’ phantom limbs into prosthetic movements.

Phantom Neuro will first target prosthetic arms, with future plans for legs and robotic control.

🔗 Source: TechCrunch

🧠 Food for thought

1️⃣ Prosthetics adoption faces persistent experience gaps despite technological advances

Despite decades of innovation, advanced prosthetics continue to face significant user adoption challenges.

Studies show rejection rates for upper limb prosthetics remain high at 23-26%, primarily due to practical limitations in comfort, durability, and insufficient sensory feedback 1.

The gap between technological capability and user satisfaction explains Phantom Neuro’s emphasis on achieving high accuracy (94%) and rapid calibration (10 minutes), directly addressing major pain points identified in clinical research.

This reflects a broader challenge in medical technology: even breakthrough innovations struggle to gain adoption without addressing the full user experience, including physical comfort, learning curve, and psychological adaptation.

The industry’s shift toward measuring success through functional restoration (Phantom claims 85% functionality restoration) rather than merely technical specifications indicates growing recognition of this user-centered approach.

2️⃣ Strategic partnerships between neural startups and established manufacturers accelerate commercialization pathways

Phantom Neuro’s strategic investment from Ottobock represents a common pattern in medical device innovation where startups with novel technology partner with established manufacturers to navigate the complex path to market.

Ottobock, a century-old company with a comprehensive prosthetics portfolio and experience integrating advanced technologies 2, provides Phantom with more than just capital—it offers manufacturing scale, distribution channels, and regulatory experience.